Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Cancer
|
January 21, 2026
Retrospective analysis of cutaneous immune-related adverse events following checkpoint inhibitor therapy in melanoma patients reveals increased risk associated with the HLA-B*51:01 allele
Mckenzie DiLeo, Samantha Oglesby, Cheuk Hong Leung, et al.
Optics Letters
|
November 4, 2008
Fluorescence monitoring of microchip capillary electrophoresis separation with monolithically integrated waveguides
Chaitanya Dongre, Ronald Dekker, Hugo J W M Hoekstra, et al.
The American Journal of Clinical Nutrition
|
April 5, 2026
Effect of Soluble Corn Fiber supplementation for 1 year on bone mass in children and adolescents, results from the MetA-Bone randomized clinical trial
Cristina Palacios, Maria A Trak-Fellermeier, Jacqueline Hernandez, et al.
Molecular Therapy. Methods & Clinical Development
|
April 11, 2022
<i>In vivo</i> CRISPR-Cas9 inhibition of hepatic LDH as treatment of primary hyperoxaluria
Rebeca Martinez-Turrillas, Angel Martin-Mallo, Saray Rodriguez-Diaz, et al.
Cancers
|
November 11, 2022
Impact of Change in Body Composition during Follow-Up on the Survival of GEP-NET
Fernando Sebastian-Valles, Nuria Sánchez de la Blanca Carrero, Víctor Rodríguez-Laval, et al.
Nature Communications
|
December 22, 2018
CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I
Nerea Zabaleta, Miren Barberia, Cristina Martin-Higueras, et al.
Archives of Pathology & Laboratory Medicine
|
June 4, 2023
Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic Approach
Susana Hernandez, Esther Conde, Aida Molero, et al.
Frontiers in Immunology
|
October 5, 2023
Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia
Cristina Calviño, Candela Ceballos, Ana Alfonso, et al.
Blood
|
September 19, 2025
Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma
Flor Navarro, Teresa Lozano, Andrea Fuentes-García, et al.
Science Advances
|
September 30, 2022
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome
Paula Rodriguez-Marquez, Maria E Calleja-Cervantes, Guillermo Serrano, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Cancer
|
January 21, 2026
Retrospective analysis of cutaneous immune-related adverse events following checkpoint inhibitor therapy in melanoma patients reveals increased risk associated with the HLA-B*51:01 allele
Mckenzie DiLeo, Samantha Oglesby, Cheuk Hong Leung, et al.
Optics Letters
|
November 4, 2008
Fluorescence monitoring of microchip capillary electrophoresis separation with monolithically integrated waveguides
Chaitanya Dongre, Ronald Dekker, Hugo J W M Hoekstra, et al.
The American Journal of Clinical Nutrition
|
April 5, 2026
Effect of Soluble Corn Fiber supplementation for 1 year on bone mass in children and adolescents, results from the MetA-Bone randomized clinical trial
Cristina Palacios, Maria A Trak-Fellermeier, Jacqueline Hernandez, et al.
Molecular Therapy. Methods & Clinical Development
|
April 11, 2022
<i>In vivo</i> CRISPR-Cas9 inhibition of hepatic LDH as treatment of primary hyperoxaluria
Rebeca Martinez-Turrillas, Angel Martin-Mallo, Saray Rodriguez-Diaz, et al.
Cancers
|
November 11, 2022
Impact of Change in Body Composition during Follow-Up on the Survival of GEP-NET
Fernando Sebastian-Valles, Nuria Sánchez de la Blanca Carrero, Víctor Rodríguez-Laval, et al.
Nature Communications
|
December 22, 2018
CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I
Nerea Zabaleta, Miren Barberia, Cristina Martin-Higueras, et al.
Archives of Pathology & Laboratory Medicine
|
June 4, 2023
Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic Approach
Susana Hernandez, Esther Conde, Aida Molero, et al.
Frontiers in Immunology
|
October 5, 2023
Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia
Cristina Calviño, Candela Ceballos, Ana Alfonso, et al.
Blood
|
September 19, 2025
Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma
Flor Navarro, Teresa Lozano, Andrea Fuentes-García, et al.
Science Advances
|
September 30, 2022
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome
Paula Rodriguez-Marquez, Maria E Calleja-Cervantes, Guillermo Serrano, et al.
Page
of 7